Cargando…

Oncolytic Virus Immunotherapy

Detalles Bibliográficos
Autores principales:	Marchini, Antonio, Ilkow, Carolina S., Melcher, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345066/ https://www.ncbi.nlm.nih.gov/pubmed/34359574 http://dx.doi.org/10.3390/cancers13153672

Ejemplares similares

Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
por: Achard, Carole, et al.
Publicado: (2018)

Oncolytic Virus Immunotherapy: Showcasing Impressive Progress in Special Issue II
por: Guo, Zong-Sheng
Publicado: (2021)

Combination strategies incorporating oncolytic viruses and immune checkpoint inhibitors for advanced melanoma: what is the evidence?
por: Wongariyapak, Amarin, et al.
Publicado: (2023)

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
por: Annels, Nicola E., et al.
Publicado: (2018)

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
por: Simpson, Guy R, et al.
Publicado: (2016)

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment
por: Khushalani, Nikhil I., et al.
Publicado: (2023)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
por: Gujar, Shashi, et al.
Publicado: (2018)

Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer
por: Rangsitratkul, Coby, et al.
Publicado: (2022)

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
por: Crupi, Mathieu J. F., et al.
Publicado: (2022)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Perspectives on immunotherapy via oncolytic viruses
por: Reale, Alberto, et al.
Publicado: (2019)

Oncolytic immunotherapy for metastatic cancer: lessons and future strategies
por: Guo, Zong-Sheng
Publicado: (2020)

Oncolytic viruses: Narcissistic or altruistic arsonists?
por: Kendall, Luke, et al.
Publicado: (2023)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Rahman, Masmudur M., et al.
Publicado: (2021)

Oncolytic viruses as immunotherapy: progress and remaining challenges
por: Aurelian, Laure
Publicado: (2016)

Oncolytic virus immunotherapy: future prospects for oncology
por: Raja, Junaid, et al.
Publicado: (2018)

Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
por: Yoo, So Young, et al.
Publicado: (2017)

Oncolytic Viruses: Priming Time for Cancer Immunotherapy
por: Russell, Luke, et al.
Publicado: (2019)

The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
por: Zolaly, Mohammed A, et al.
Publicado: (2023)

Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy?
por: Prestwich, Robin J, et al.
Publicado: (2008)

CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
por: Pourchet, Aldo, et al.
Publicado: (2016)

High-throughput screening to enhance oncolytic virus immunotherapy
por: Allan, KJ, et al.
Publicado: (2016)

Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies
por: Jhawar, Sachin R., et al.
Publicado: (2017)

Oncolytic viruses: a new class of immunotherapy drugs
por: Kaufman, Howard L., et al.
Publicado: (2015)

Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
por: Tian, Yaomei, et al.
Publicado: (2022)

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
por: Li, Qingbo, et al.
Publicado: (2022)

Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
por: Omole, Richard Kolade, et al.
Publicado: (2022)

Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
por: Muthukutty, Palaniyandi, et al.
Publicado: (2023)

Oncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate Tumors
por: Annels, Nicola E., et al.
Publicado: (2020)

Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies
por: Fergusson, Dean A., et al.
Publicado: (2019)

Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients
por: Pandha, Hardev, et al.
Publicado: (2015)

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy
por: Swift, Stephanie L., et al.
Publicado: (2016)

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
por: Hamid, Omid, et al.
Publicado: (2017)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
por: Guo, Zong Sheng, et al.
Publicado: (2019)

Erratum: Oncolytic viruses: a new class of immunotherapy drugs
por: Kaufman, Howard L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_abtt780trpcj6tqgstpg27cgcp